SB 219 Summary

• Requires medical directors of law enforcement and emergency medical services agencies to report to the INSPECT program when emergency medical services providers administer overdose intervention drugs, including patient name, date of birth, drug code number, administration date, quantity, and medical director's DEA registration number.

• Establishes reporting timeline requiring medical directors to transmit overdose intervention drug information within 24 hours of administration, or by the end of the next business day if the office is closed.

• Creates the INSPECT peer review subcommittee consisting of the INSPECT director (chairperson), two physicians, two pharmacists, one each of osteopathic physician, dentist, podiatrist, veterinarian, advanced practice nurse, physician assistant, and optometrist, plus representatives from mental health/addiction, attorney general's office, and state health department.

• Authorizes the peer review subcommittee to identify practitioners prescribing or dispensing outside professional standards, request explanations within 30 days, and refer non-compliant practitioners to the attorney general for investigation.

• Maintains confidentiality of practitioner materials submitted to the subcommittee unless a referral to the attorney general has been made; effective July 1, 2018.